EQUAMIRA Trademark

Trademark Overview

On Thursday, January 19, 2017, a trademark application was filed for EQUAMIRA with the United States Patent and Trademark Office. The USPTO has given the EQUAMIRA trademark a serial number of 87307045. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 31, 2020. This trademark is owned by Coherus BioSciences, Inc.. The EQUAMIRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune diseases
equamira

General Information

Serial Number87307045
Word MarkEQUAMIRA
Filing DateThursday, January 19, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 31, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 26, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCoherus BioSciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065
Party NameCoherus BioSciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065

Trademark Events

Event DateEvent Description
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, February 16, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, August 31, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 31, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 29, 2020SOU EXTENSION 5 GRANTED
Friday, January 24, 2020SOU EXTENSION 5 FILED
Wednesday, January 29, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 24, 2020TEAS EXTENSION RECEIVED
Tuesday, October 15, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 15, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 26, 2019SOU EXTENSION 4 GRANTED
Wednesday, June 26, 2019SOU EXTENSION 4 FILED
Wednesday, June 26, 2019TEAS EXTENSION RECEIVED
Saturday, January 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 24, 2019SOU EXTENSION 3 GRANTED
Thursday, January 24, 2019SOU EXTENSION 3 FILED
Thursday, January 24, 2019TEAS EXTENSION RECEIVED
Friday, July 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 25, 2018SOU EXTENSION 2 GRANTED
Wednesday, July 25, 2018SOU EXTENSION 2 FILED
Wednesday, July 25, 2018TEAS EXTENSION RECEIVED
Friday, January 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 24, 2018SOU EXTENSION 1 GRANTED
Wednesday, January 24, 2018SOU EXTENSION 1 FILED
Wednesday, January 24, 2018TEAS EXTENSION RECEIVED
Tuesday, July 25, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 30, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 10, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 15, 2017ASSIGNED TO EXAMINER
Thursday, January 26, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 23, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

equamira diseases autoimmune treatment preparations pharmaceutical